A natural remedy for alcohol-induced fatty liver disease found in licorice root
(Natural News) Drinking alcohol has become a major part of people’s social lives. People drink when they are happy, sad, stressed, or feeling any other emotion. There is some benefit to moderate drinking, but too much can harm a person’s health. In particular, this can lead to a condition called alcohol-induced fatty disease. A study in BMC... (Source: NaturalNews.com)
Source: NaturalNews.com - November 5, 2018 Category: Consumer Health News Source Type: news

Fatty Liver Disease in the Spotlight at The Liver Meeting Fatty Liver Disease in the Spotlight at The Liver Meeting
Current and future treatments for fatty liver disease, particularly nonalcoholic steatohepatitis, the most prevalent liver disease in the United States, will be explored at The Liver Meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 2, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Licorice root is good for the liver
In this study, which was published in BMC Complementary and Alternative Medicine, the researchers... (Source: NaturalNews.com)
Source: NaturalNews.com - November 2, 2018 Category: Consumer Health News Source Type: news

Medical News Today: 'Natural protein' could reverse obesity-related diabetes, fatty liver
Increasing the 'natural protein' BP3 in obese mice reduces fat mass, high blood sugar, and fatty liver fats by firing up metabolism, a new study reveals. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 30, 2018 Category: Consumer Health News Tags: Obesity / Weight Loss / Fitness Source Type: news

Recent research suggests that even low exposure to glyphosate can contribute to liver damage
(Natural News) Back in 2015, the American Liver Foundation estimated that at least one in four Americans was living with non-alcoholic fatty liver disease (NAFLD), an illness that can affect even those who drink little or no alcohol. People in their 40s and 50s are most vulnerable, especially those who carry extra weight around their... (Source: NaturalNews.com)
Source: NaturalNews.com - October 29, 2018 Category: Consumer Health News Source Type: news

Novartis, Pfizer join forces on potentially lucrative fatty liver disease
Novartis AG and Pfizer Inc are teaming up to develop treatments for a liver disease many drug companies believe will become a hugely lucrative market, as it is tied to the obesity and diabetes epidemics. (Source: Reuters: Health)
Source: Reuters: Health - October 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Clues to the link between obesity and liver cancer-and identification of a new risk group
(Monash University) New research has found a previously overlooked group of obese people may be at risk of developing deadly liver cancer. Most obese individuals who develop liver cancer first develop non-alcoholic fatty liver disease, and then the more severe non-alcoholic steatohepatitis. This can lead to cirrhosis and liver failure. However, this research reveals pathways to the development of liver cancer in obese people that are not reliant on the development of non-alcoholic steatohepatitis or cirrhosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 25, 2018 Category: Cancer & Oncology Source Type: news

Shellfish and tea? Compounds found in both protect you from a progressive form of nonalcoholic fatty liver disease
(Natural News) Sipping tea in between mouthfuls of taurine-rich shellfish sounds like a strange combination. However, Chinese researchers say this is an excellent way to protect your liver from certain diseases. Their new study shows that the combination of taurine and tea polyphenols can prevent the onset of nonalcoholic steatohepatitis (NASH). NASH is the progressive... (Source: NaturalNews.com)
Source: NaturalNews.com - October 24, 2018 Category: Consumer Health News Source Type: news

Liver fat can be quickly and significantly reduced with a gastrointestinal hormone
(Natural News) A study published in The Lancet reported that NGM282, a non-tumorigenic variant of a hormone found in the gastrointestinal tract, was able to reduce the liver fat content in patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). According to researchers, the findings demonstrated the potential of the compound to be used in treating both... (Source: NaturalNews.com)
Source: NaturalNews.com - October 24, 2018 Category: Consumer Health News Source Type: news

10 Ways to Keep Your Heart Healthy
No one ever had fun visiting the cardiologist. ­Regardless of how good the doc might be, it’s always a little scary thinking about the health of something as fundamental as the heart. But there are ways to take greater control—to ensure that your own heart health is the best it can be—even if you have a family history of cardiovascular disease. Although 50% of cardiovascular-disease risk is genetic, the other 50% can be modified by how you live your life, according to Dr. Eugenia Gianos, director of Women’s Heart Health at Lenox Hill Hospital in New York City. “This means you can greatly ...
Source: TIME: Health - October 17, 2018 Category: Consumer Health News Authors: Lisa Lombardi and Jamie Ducharme Tags: Uncategorized Baby Boomer Health heart health Source Type: news

Sleeping beauty helps identify genes involved in a fatty liver-associated liver cancer
(Osaka University) Hepatocellular carcinoma, a deadly form of liver cancer, is increasingly being linked to non-alcoholic fatty liver disease; however, the underlying genetic mechanism of disease progression had remained unknown. Using a Sleeping Beauty mutagenesis screen, Osaka University researchers found that Sav1 and downstream components of the Hippo signaling pathway are drivers of the development of liver cancer associated with fatty liver disease. These findings pave the way for liver cancer treatments targeting the Hippo pathway. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

Web-Based Lifestyle Program Works for Liver Disease Patients
TUESDAY, Oct. 16, 2018 -- Web-based programs may be effective in helping patients make lifestyle changes to control non-alcoholic fatty liver disease (NAFLD), according to a study published in the November issue of the Journal of Hepatology. Arianna... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2018 Category: Pharmaceuticals Source Type: news

Modest Alcohol Consumption May Reduce Mortality in NAFLD
FRIDAY, Oct. 12, 2018 -- For patients with nonalcoholic fatty liver disease (NAFLD), modest alcohol consumption is associated with a reduction in all-cause mortality, while drinking 1.5 or more drinks per day may increase mortality, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 12, 2018 Category: Pharmaceuticals Source Type: news

NIH awards Steve Farber $3.3-million to identify medicines for cardiovascular disease
(Carnegie Institution for Science) Carnegie's Department of Embryology scientist Steven Farber and team have been awarded a 5-year $3.3-million NIH grant to identify novel pharmaceuticals for combatting a host of diseases associated with altered levels of lipoproteins like LDL ('bad cholesterol'). Obesity, diabetes, cardiovascular disease, fatty liver disease, and metabolic syndrome have all been linked to changes in plasma lipoproteins. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 10, 2018 Category: International Medicine & Public Health Source Type: news

Obesity, Weight Gain Linked to Fibrosis Progression in NAFLD Obesity, Weight Gain Linked to Fibrosis Progression in NAFLD
Obesity and weight gain were independently associated with an increased risk for fibrosis progression in patients with nonalcoholic fatty liver disease (NAFLD), a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Fatty Liver (NASH)
Title: Fatty Liver (NASH)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/4/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - October 4, 2018 Category: Nutrition Source Type: news

Hepatic Steatosis Across the Pediatric Age Spectrum Hepatic Steatosis Across the Pediatric Age Spectrum
Is fatty liver disease more common in young children than previously thought? Using abdominal CT, this study investigated the prevalence of hepatic steatosis in a cohort of healthy children.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 25, 2018 Category: Consumer Health News Tags: Pharmacist Journal Article Source Type: news

Risk of NAFLD in Celiac Patients on a Gluten-free Diet Risk of NAFLD in Celiac Patients on a Gluten-free Diet
Does a gluten-free diet impact the risk of developing nonalcoholic fatty liver disease in patients with celiac disease?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 20, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Olives are good at reducing fatty liver
(Natural News) Researchers have found an effective new treatment for hyperlipidemia with oleanolic acid (OA), a natural compound found in olives (Olea europaea). The study, which was led by researchers from China Pharmaceutical University and Nanjing Medical University, looked at the ability of olives to lower cholesterol levels in patients diagnosed with hyperlipidemia. While better known as a... (Source: NaturalNews.com)
Source: NaturalNews.com - September 19, 2018 Category: Consumer Health News Source Type: news

Viking shares surge after fatty liver drug trial
Viking Therapeutics Inc's shares more than doubled in value on Tuesday after promising data from a mid-stage trial of its fatty liver drug were seen as topping that from larger rival Madrigal Pharmaceuticals . (Source: Reuters: Health)
Source: Reuters: Health - September 18, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Big data studies scrutinize links between fatty liver disease and how cells make energy
(American Society for Biochemistry and Molecular Biology) Three recent studies investigate changes in mitochondria, the cell's energy producers, as fatty liver disease (NAFLD) progresses to steatohepatosis (NASH). The first two studies illuminate how mitochondrial energy production stutters and fails; the third describes how changes to the liver during disease progression affect the organ's use of nutrients to produce energy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 14, 2018 Category: International Medicine & Public Health Source Type: news

Medical News Today: Blocking this protein may keep obesity, diabetes at bay
Deleting the RNA-silencing protein Ago2 in mice's livers changed the animals' energy metabolism and prevented obesity, diabetes, and fatty liver disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 12, 2018 Category: Consumer Health News Tags: Obesity / Weight Loss / Fitness Source Type: news

Vitamin E helps diminish a type of fatty liver disease in children
A specific form of vitamin E improved the most severe form of fatty liver disease in some children, according to a study funded by the NIH. Results appear in the April 27 issue of theJournal of the American Medical Association. A previous study found vitamin E effective in some adults with the disease. (Source: NIDDK News)
Source: NIDDK News - September 10, 2018 Category: Endocrinology Source Type: news

Scientists block RNA silencing protein in liver to prevent obesity and diabetes in mice
(Cincinnati Children's Hospital Medical Center) Obesity and its related ailments like type 2 diabetes and fatty liver disease pose a major global health burden, but researchers report in Nature Communications that blocking an RNA-silencing protein in the livers of mice keeps the animals from getting fat and diabetic conditions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 10, 2018 Category: International Medicine & Public Health Source Type: news

Severe NAFLD Boosts Liver Cancer Risk Severe NAFLD Boosts Liver Cancer Risk
People with advanced cases of nonalcoholic fatty liver disease (NAFLD) may need to be monitored for liver cancer, a large U.S. study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 6, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Losing just six hours of sleep could increase diabetes risk, study finds
(American Physiological Society) Losing a single night's sleep may affect the liver's ability to produce glucose and process insulin, increasing the risk of metabolic diseases such as hepatic steatosis (fatty liver) and type 2 diabetes. The findings of the mouse study are published ahead of print in the American Journal of Physiology--Endocrinology and Metabolism. The research was chosen as an APSselect article for September. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 5, 2018 Category: International Medicine & Public Health Source Type: news

Severe fatty liver disease boosts risk for liver cancer
(Reuters Health) - People with advanced cases of nonalcoholic fatty liver disease (NAFLD) may need to be watched for liver cancer, a large U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - September 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Novel concepts for the diagnosis of fatty liver and personalized treatment
(Deutsches Zentrum fuer Diabetesforschung DZD) Almost one in three adults suffer from non-alcoholic fatty liver. For the affected people this increases the risk of complications such as liver cancer, diabetes, high blood pressure and stroke. In a review article in The Lancet Diabetes& Endocrinology, Nobert Stefan and Hans-Ulrich H ä ring from the DZD and Kenneth Cusi from the University of Florida summarize current research findings and show how this knowledge can be used for personalized risk prognosis and individualized treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 31, 2018 Category: International Medicine & Public Health Source Type: news

Postpartum Acute Fatty Liver of Pregnancy Postpartum Acute Fatty Liver of Pregnancy
Acute fatty liver of pregnancy can pose significant risk of mortality to healthy women, and as this case demonstrates, the clinical presentation can be highly variable and nonspecific.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 22, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

More protein after weight loss may reduce fatty liver disease
(American Physiological Society) Increasing the amount of protein in the diet may reduce the liver's fat content and lower the risk of diabetes in people with nonalcoholic fatty liver disease (NAFLD). The study is published ahead of print in the American Journal of Physiology--Endocrinology and Metabolism. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 16, 2018 Category: International Medicine & Public Health Source Type: news

Treat your fatty liver disease naturally with a traditional Chinese herbal powder
(Natural News) A traditional Chinese herbal medicine called Sinisan can help treat nonalcoholic fatty liver disease (NAFLD), according to a study published in the journal BMC Complementary and Alternative Medicine. Researchers from Beijing University of Chinese Medicine in China evaluated the beneficial effects of Sinisan on NAFLD. Sinisan is made up of four herbal medicines:... (Source: NaturalNews.com)
Source: NaturalNews.com - August 12, 2018 Category: Consumer Health News Source Type: news

Even Light Drinking May Make Fatty Liver Disease Worse Even Light Drinking May Make Fatty Liver Disease Worse
People non-alcoholic fatty liver disease (NAFLD) may still need to avoid alcohol if they want to prevent their liver damage from getting worse, a Korean study suggests. The researchers examined data on 58,927 Korean young and middle aged adults with NAFLD who had low levels of fibrosis. After following half of these patients for at least 8.3 years, 5,630 people had progressed from low to more ...Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Even light drinking may make fatty liver disease worse
(Reuters Health) - People who have fatty liver disease that wasn't caused by heavy drinking may still need to avoid alcohol if they want to prevent their liver damage from getting worse, a Korean study suggests. (Source: Reuters: Health)
Source: Reuters: Health - August 8, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Aortic atherosclerotic plaque inflammation may contribute to the progression of fatty liver disease to liver fibrosis
(Boston University School of Medicine) A new study sheds light on the long-term effects of highly inflamed plaques on the progression of liver fibrosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 2, 2018 Category: International Medicine & Public Health Source Type: news

Shear-wave elastography works to evaluate liver disease
Two-dimensional shear-wave elastography is an effective tool for identifying...Read more on AuntMinnie.comRelated Reading: AIUM: Can deep learning classify liver fibrosis on US? Adding blood test to US improves liver cancer diagnosis How accurate are SRU guidelines for advanced fibrosis? Spleen stiffness correlates with cirrhosis complication Quantitative ultrasound method stages fatty liver (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 30, 2018 Category: Radiology Source Type: news

HIV May Up Risk for Liver Steatosis in Mono-infected Patients
(MedPage Today) -- Earlier intervention on'manageable factors'for fatty liver disease may help in this population (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 27, 2018 Category: Primary Care Source Type: news

Increased Plasma Proneurotensin Levels Identify NAFLD Increased Plasma Proneurotensin Levels Identify NAFLD
A new study investigates the relationship between plasma proneurotensin levels and nonalcoholic fatty liver disease or nonalcoholic steatohepatitis.Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 23, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Fatty liver disease pandemic needs 'gold standard' human-relevant research
(Humane Society International) New study calls for human-based tools to unravel the pathogenesis of non-alcoholic steatohepatitis (NASH). The contribution of in silico, in vitro and pathways-based systems biology approaches to unraveling the pathogenesis of this disease are described, and how this human-relevant research can be used for anti-NASH drug development. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 18, 2018 Category: International Medicine & Public Health Source Type: news

TGen-led study shows DNA methylation related to liver disease among obese patients
(The Translational Genomics Research Institute) A TGen-led team has identified how DNA methylation is associated with a condition known as non-alcoholic fatty liver disease (NAFLD), which can lead to liver cirrhosis and death, and is one of the leading indicators for liver transplants. In one of the most exacting studies of its kind, TGen scientists found evidence that DNA methylation has a role in the initiation of NAFLD-related fibrosis, according to a study published in the journal Clinical Epigenetics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 18, 2018 Category: International Medicine & Public Health Source Type: news

Economic burden of fatty liver disease in US is $32 billion annually, new study finds
(Intermountain Medical Center) Nonalcoholic fatty liver disease, or NAFLD, which affects roughly 100 million Americans, costs the United States healthcare system $32 billion annually, according to a first-of-its-kind study by Intermountain Healthcare researchers on the economic impact of the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 3, 2018 Category: International Medicine & Public Health Source Type: news

Fatty liver disease symptoms: Are you at risk? These four signs could lead to organ damage
FATTY liver disease is a condition with several types - non-alcoholic fatty liver disease is one of the main types. This is usually caused by being very overweight. But before being diagnosed, what are the symptoms to look out for, and are you at risk? (Source: Daily Express - Health)
Source: Daily Express - Health - June 21, 2018 Category: Consumer Health News Source Type: news

Liver Cancer Doubled in High-Income Countries Liver Cancer Doubled in High-Income Countries
Rates of liver cancer have doubled since the 1990s in high-income countries and are largely due to infection with hepatitis B and C, as well as nonalcoholic fatty liver disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 18, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Israeli Company Galmed Gets Positive Trial Results for Liver Drug Israeli Company Galmed Gets Positive Trial Results for Liver Drug
Galmed Pharmaceuticals said on Tuesday patients in a mid-stage trial for its treatment for non-alcoholic steatohepatitis (NASH), a fatty liver disease linked to obesity, showed a statistically significant reduction in liver fat.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 13, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Israeli company Galmed gets positive trial results for liver drug
TEL AVIV (Reuters) - Galmed Pharmaceuticals said on Tuesday patients in a mid-stage trial for its treatment for NASH, a fatty liver disease linked to obesity, showed a statistically significant reduction in liver fat. (Source: Reuters: Health)
Source: Reuters: Health - June 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

High Costs for Diagnosis, Care of Nonalcoholic Fatty Liver Disease
MONDAY, June 11, 2018 -- The health care costs associated with nonalcoholic fatty liver disease (NAFLD) are considerable, especially at first diagnosis, according to a study published online May 18 in Hepatology. Alina M. Allen, M.D., from the Mayo... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 11, 2018 Category: Pharmaceuticals Source Type: news

Too young for such an "old" condition: 8-year-olds now being diagnosed with nonalcoholic fatty liver disease
(Natural News) Adults who have an unhealthy lifestyle are often diagnosed with nonalcoholic fatty liver disease (NAFLD). But according to a study, there is an alarming link “between childhood obesity and juvenile liver health problems.” The study on children involved researchers from Harvard Medical School based on Project Viva of Massachusetts. It confirmed a connection between childhood obesity and... (Source: NaturalNews.com)
Source: NaturalNews.com - June 6, 2018 Category: Consumer Health News Source Type: news

Madrigal Pharma Shares Double After Successful Phase II Results For Fatty Liver Drug
Competition is tough for a drug to cure fatty liver disease. After today's 150% jump, is Madrigal Pharmaceuticals the next darling of the biotech sector? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 31, 2018 Category: Pharmaceuticals Authors: Karl Kaufman, Contributor Tags: NASDAQ:MDGL NASDAQ:GILD NYSE:AGN NASDAQ:VKTX NASDAQ:ICPT Source Type: news

Madrigal Pharma more than doubles after liver drug study success
(Reuters) - Madrigal Pharmaceuticals Inc's shares more than doubled after mid-stage trial data showed its lead drug reduced liver fat in patients with fatty liver disease, placing it ahead of larger rivals to tap into a potential market worth $30 billion. (Source: Reuters: Health)
Source: Reuters: Health - May 31, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Madrigal Pharma's liver drug succeeds in study, shares soar
(Reuters) - Madrigal Pharmaceuticals Inc's lead experimental drug achieved the main goal of reducing liver fat in patients with fatty liver disease in a mid-stage study, sending its shares surging 66 percent in premarket trading on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - May 31, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

We could reverse aging by removing wrinkles inside our cells, study suggests
(University of Virginia Health System) A new discovery about the effects of aging in our cells could allow doctors to cure or prevent diabetes, fatty liver disease and other metabolic diseases -- and possibly even turn back the clock on aging itself. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 29, 2018 Category: Biology Source Type: news